# Intra-operative Use of Indigo Carmine Dye for the Delineation of Ill Defined Tumor Borders Using Stereotactic Injection

> **NCT01767415** · PHASE1,PHASE2 · COMPLETED · sponsor: **Weill Medical College of Cornell University** · enrollment: 10 (actual)

## Conditions studied

- Brain Tumors With Ill-defined Margins

## Interventions

- **DRUG:** Indigo carmine

## Key facts

- **NCT ID:** NCT01767415
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2014-04
- **Final completion:** 2014-09
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2018-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01767415

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01767415, "Intra-operative Use of Indigo Carmine Dye for the Delineation of Ill Defined Tumor Borders Using Stereotactic Injection". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01767415. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*